Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-28

Clinical Trial Update: The Effect of Piracetam on Diabetic Peripheral Neuropathy Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial at Ain Shams University evaluating the effect of piracetam on diabetic peripheral neuropathy. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Piracetam (piracetam)

Snippet

Sponsor: Ain Shams University | Conditions: Diabetic Peripheral Neuropathy | Phase 4 | Status: NOT_YET_RECRUITING